Skip to main content
. 2023 Mar 21;7(14):3686–3694. doi: 10.1182/bloodadvances.2022009379

Table 2.

Summary of all participants’ results for MRD-negative samples (9-12)

Marker
RUNX1::RUNX1T1
CBFB::MYH11
PML::RARA
NPM1
Sample 9 10 11 12
n 23 23 22 23
False-positive rate 0 (0%) 1 (4.3%) 1 (4.5%) 6 (26.1%)

n, number of laboratories that returned results.